Within myeloid subtypes, CPLDneg-CH participants were at demonstrable risk of chronic myeloid leukemia (CML), myelodysplastic syndrome (MDS) and myeloproliferative neoplasia (MPN). The gene discussed is C4B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.